Stoke Therapeutics (STOK) Institutional Ownership

Of the 158 institutional investors that purchased Stoke Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Toronto Dominion Bank ($6.35M), BlackRock Inc. ($5.88M), Jupiter Topco LLC ($1.81M), California State Teachers Retirement System ($1.61M), RTW Investments LP ($1.32M), Corient Private Wealth LLC ($1.32M), and Janus Henderson Group PLC ($1.28M).

Institutional investors have bought a total of 22,477,835 shares in the last 24 months. This purchase volume represents approximately $684.76M in transactions.

Of the 44 institutional investors that sold Stoke Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Marshall Wace LLP ($1.53M), Baker BROS. Advisors LP ($1.30M), Skorpios Trust ($1M), Royal Bank of Canada ($914.16K), Granahan Investment Management LLC ($341.02K), Assenagon Asset Management S.A. ($320.71K), and Bank of America Corp DE ($298.64K).

Institutional investors have sold a total of 6,939,967 shares in the last 24 months. This volume of shares sold represents approximately $192.95M in transactions.